Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Diabetes
What insulin pump features and settings do you utilize in patients with diabetes and end stage renal disease on intermittent hemodialysis or home peritoneal dialysis?
Related Questions
Under what circumstances would you use pasireotide in the management of insulinoma-associated hypoglycemia?
How do you counsel patients on the use of berberine to prevent the progression of prediabetes to type 2 diabetes mellitus?
How do you approach adjusting insulin pump settings in patients who have received intra-articular corticosteroid injections?
What is the preferred first-line non-insulin agent in patients with ketosis-prone diabetes during "remission" and evidence of preserved beta cell function?
How has the use of CGMs informed or improved your management of patients with pre diabetes or diabetes not on insulin?
In patients with T1DM, when would you consider the use of amylin analogues for control of post prandial hyperglycemia?
Does injectable semaglutide have a higher glucose-lowering efficiency than oral semaglutide?
How do you titrate the dose of an ACE inhibitor in a patient with type 1 diabetes mellitus who is normotensive but has moderately increased albuminuria?
For patients on peritoneal dialysis with type 2 diabetes mellitus, do you have a preferred long- acting insulin and time of insulin administration?
Should long-acting subcutaneous insulin be started upfront in addition to regular insulin infusion for patients with diabetic ketoacidosis?
